Selected
Type of publications
Topics
Available to download in languages
Regions
Diseases
2605 results found
2023 ∙ Ayyalasomayajula, S. Dhawan, A. Karattuthodi, M. S. Thorakkattil, S. A. Abdulsalim, S. Elnaem, M. H. Sridhar, S. Unnikrishnan, M. K.
A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Rating:
Not applicable
2023 ∙ Alhandod, T. A. Rabbani, S. I. Almuqbil, M. Alshehri, S. Hussain, S. A. Alomar, N. F. Mir, M. A. Asdaq, S. M. B.
A Systematic Review on the Safety and Efficacy of COVID-19 Vaccines Approved in Saudi Arabia
  • Vaccine/vaccination
  • Adults
  • Older adults
  • Saudi Arabia
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Rating:
Critically low
2023 ∙ Segal, H. A. Rashid, N.
A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Economic aspects
Rating:
Not applicable
2023 ∙ Kumar, G. Jena, S. Snigdha, N. T. Basha, S. Narayanan, J. K. Luke, A. M.
Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis
  • Vaccine/vaccination
  • All age groups
  • Healthcare workers
  • India
  • COVID-19
  • Acceptance
Rating:
Not applicable
2023 ∙ Derbie, A. Mekonnen, D. Misgan, E. Maier, M. Woldeamanuel, Y. Abebe, T.
Acceptance of human papillomavirus vaccination and parents’ willingness to vaccinate their adolescents in Ethiopia: a systematic review and meta-analysis
  • Parents/caregivers
  • Ethiopia
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Rating:
Not applicable
2023 ∙ Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
  • Newborn
  • Children
  • Adolescents
  • Adults
  • Pneumococcal disease
  • Rotavirus
  • Human papillomavirus (HPV)
  • Meningococcal disease
  • Mumps
  • Measles
  • Rubella
  • Economic aspects
Rating:
Not applicable
2023 ∙ Dadari, I. Belt, R. V. Iyengar, A. Ray, A. Hossain, I. Ali, D. Danielsson, N. Sodha, S. V.
Achieving the IA2030 Coverage and Equity Goals through a Renewed Focus on Urban Immunization
  • Newborn
  • Children
  • Adolescents
  • Coverage
  • Ethical issues
Rating:
Not applicable
2023 ∙ Amisha, F. Saluja, P. Malik, P. Van Rhee, F.
Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: A systematic review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Nabizadeh, F. Noori, M. Rahmani, S. Hosseini, H.
Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Pichichero, Michael Malley, Richard Kaur, Ravinder Zagursky, Robert Anderson, Porter
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Efficacy/effectiveness
Rating:
Critically low